These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33345378)

  • 1. Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran.
    Radfar SR; Nematollahi P; Tayeri K; Dehghan H; Janani M; Higgs P; Mohsenifar S; Noroozi A
    Drug Alcohol Rev; 2021 May; 40(4):572-579. PubMed ID: 33345378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
    Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
    J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study.
    Twahirwa Rwema JO; Nizeyimana V; Prata NM; Okonkwo NE; Mazzei AA; Muhirwa S; Rukundo A; Lucas L; Niyigena A; Makuza JD; Beyrer C; Baral SD; Kagaba A
    Harm Reduct J; 2021 Dec; 18(1):130. PubMed ID: 34911554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Armenta RF; Collins KM; Strathdee SA; Bulterys MA; Munoz F; Cuevas-Mota J; Chiles P; Garfein RS
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):425-431. PubMed ID: 28284258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
    Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
    Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.
    Kizza FN; List J; Nkwata AK; Okwera A; Ezeamama AE; Whalen CC; Sekandi JN
    BMC Infect Dis; 2015 Mar; 15():165. PubMed ID: 25879423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
    Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
    Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?
    Likindikoki SL; Mmbaga EJ; Leyna GH; Moen K; Makyao N; Mizinduko M; Mwijage AI; Faini D; Leshabari MT; Meyrowitsch DW
    Harm Reduct J; 2020 Mar; 17(1):18. PubMed ID: 32209110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernández D
    Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies.
    Uusküla A; Rannap J; Weijler L; Abagiu A; Arendt V; Barrio G; Barros H; Brummer-Korvenkontio H; Casabona J; Croes E; Jarlais DD; Seguin-Devaux C; Dudás M; Eritsyan K; Folch C; Hatzakis A; Heimer R; Heinsbroek E; Hope V; Jipa R; Ķīvīte-Urtāne A; Levina O; Lyubimova A; Malczewski A; Matser A; McAuley A; Meireles P; Mravčík V; Op de Coul E; Ojavee SE; Parés-Badell O; Prins M; Pulido J; Romanyak E; Rosinska M; Seyler T; Stone J; Sypsa V; Talu A; Tarján A; Taylor A; Vickerman P; Vorobjov S; Dolan K; Wiessing L;
    Addiction; 2023 Nov; 118(11):2177-2192. PubMed ID: 37991429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
    Roshanfekr P; Karimi SE; Narouee S; Moftakhar L; Vameghi M; Ali D; Higgs P; Soleimanvandiazar N
    Front Public Health; 2023; 11():1253407. PubMed ID: 37915820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
    Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
    Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low HIV testing rate and its correlates among men who inject drugs in Iran.
    Shokoohi M; Karamouzian M; Osooli M; Sharifi H; Fahimfar N; Haghdoost A; Zamani O; Mirzazadeh A
    Int J Drug Policy; 2016 Jun; 32():64-9. PubMed ID: 27157980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.